Economic Burden and Health Care Resource Utilization of Patients With Eosinophilic Esophagitis in the United States
Patients with EoE had higher annual costs and HCRU than non-EoE controls, indicating a substantial economic burden, particularly among patients with EoE with prior esophageal dilation.
Authors
- Angela Khodzhayev
- Ryan B. Thomas (ORCID: https://orcid.org/0000-0002-1141-2073)
- Sarette T. Tilton
- Tiffany Pela
- Andrew J. Epstein (ORCID: https://orcid.org/0000-0001-5078-6564)
- Eilish McCann (ORCID: https://orcid.org/0000-0001-7156-9390)
- Chao Chen (ORCID: https://orcid.org/0000-0002-4422-1716)
- Mirna Chehade
- Degang Wang
Institutions
- Regeneron (United States) (US)
- Sanofi (United States) (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1097/mcg.0000000000002188
- Citations
- 3
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 6.02